KLK3 and prostate carcinoma: Also, PSA is the first and only one serum marker for the diagnosis of prostate cancer with a positive predictive value of 47% approved by the U.S. Food and Drug Administration since 1986; it seems to neither predict response to therapy nor present tumor progression [10–12].